Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |